{"entity":{"type":"insider","cik":"0001612090","url":"/insider/0001612090","json_url":"/insider/0001612090.json","name":"Soffer Gad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2015-08-19","last":"2017-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Soffer Gad","source":"filing","n_filings":13,"first_seen":"2015-08-19","last_seen":"2017-11-17"}],"transactions":[{"id":5210755,"accession":"0001209191-17-061621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-061621","line_url":"/filing/0001209191-17-061621#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","total_whole":"105,000","shares_owned_after":256236.0,"shares_owned_after_display":"256,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-17","filed_date":"2017-11-17","scope":"insider"},{"id":5120824,"accession":"0001209191-17-049451","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-049451","line_url":"/filing/0001209191-17-049451#line-3","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2464.0,"shares_display":"2,464","price_per_share":14.53,"price_display":"14.53","price_state":"stated","total_value":35801.92,"total_display":"35,801.92","total_whole":"35,802","shares_owned_after":259090.0,"shares_owned_after_display":"259,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-17","scope":"insider"},{"id":5120821,"accession":"0001209191-17-049451","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-049451","line_url":"/filing/0001209191-17-049451#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","total_whole":"105,000","shares_owned_after":257409.0,"shares_owned_after_display":"257,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-17","scope":"insider"},{"id":4540935,"accession":"0001209191-17-033185","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-033185","line_url":"/filing/0001209191-17-033185#line-4","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5674.0,"shares_display":"5,674","price_per_share":15.19,"price_display":"15.19","price_state":"stated","total_value":86188.06,"total_display":"86,188.06","total_whole":"86,188","shares_owned_after":264409.0,"shares_owned_after_display":"264,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-16","filed_date":"2017-05-17","scope":"insider"},{"id":4540931,"accession":"0001209191-17-033185","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-033185","line_url":"/filing/0001209191-17-033185#line-3","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":15.13,"price_display":"15.13","price_state":"stated","total_value":105910.0,"total_display":"105,910.00","total_whole":"105,910","shares_owned_after":259527.0,"shares_owned_after_display":"259,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"},{"id":4708075,"accession":"0001209191-17-020262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-020262","line_url":"/filing/0001209191-17-020262#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":266527.0,"shares_owned_after_display":"266,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-10","filed_date":"2017-03-13","scope":"insider"},{"id":4557608,"accession":"0001209191-17-011766","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-011766","line_url":"/filing/0001209191-17-011766#line-4","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7273.0,"shares_display":"7,273","price_per_share":15.62,"price_display":"15.62","price_state":"stated","total_value":113604.26,"total_display":"113,604.26","total_whole":"113,604","shares_owned_after":269027.0,"shares_owned_after_display":"269,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-16","scope":"insider"},{"id":4557605,"accession":"0001209191-17-011766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-011766","line_url":"/filing/0001209191-17-011766#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":15.22,"price_display":"15.22","price_state":"stated","total_value":106540.0,"total_display":"106,540.00","total_whole":"106,540","shares_owned_after":262538.0,"shares_owned_after_display":"262,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-16","scope":"insider"},{"id":4410898,"accession":"0001209191-17-010165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-010165","line_url":"/filing/0001209191-17-010165","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (EVP & Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6274.0,"shares_display":"6,274","price_per_share":15.465266177876952,"price_display":"15.47","price_state":"stated","total_value":97029.08,"total_display":"97,029.08","total_whole":"97,029","shares_owned_after":269938.0,"shares_owned_after_display":"269,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-02-13","scope":"insider","n_lines":2},{"id":2181332,"accession":"0001209191-16-151759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151759","line_url":"/filing/0001209191-16-151759#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1480.0,"shares_display":"1,480","price_per_share":18.41,"price_display":"18.41","price_state":"stated","total_value":27246.8,"total_display":"27,246.80","total_whole":"27,247","shares_owned_after":230812.0,"shares_owned_after_display":"230,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-22","scope":"insider"},{"id":2181179,"accession":"0001209191-16-150727","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-150727","line_url":"/filing/0001209191-16-150727#line-4","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7136.0,"shares_display":"7,136","price_per_share":19.27,"price_display":"19.27","price_state":"stated","total_value":137510.72,"total_display":"137,510.72","total_whole":"137,511","shares_owned_after":232292.0,"shares_owned_after_display":"232,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-16","filed_date":"2016-11-16","scope":"insider"},{"id":2181171,"accession":"0001209191-16-150727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-150727","line_url":"/filing/0001209191-16-150727#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9582.0,"shares_display":"9,582","price_per_share":20.55,"price_display":"20.55","price_state":"stated","total_value":196910.1,"total_display":"196,910.10","total_whole":"196,910","shares_owned_after":225667.0,"shares_owned_after_display":"225,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-16","scope":"insider"},{"id":2516458,"accession":"0001209191-16-137678","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-137678","line_url":"/filing/0001209191-16-137678","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5356.0,"shares_display":"5,356","price_per_share":22.41218073188947,"price_display":"22.41","price_state":"stated","total_value":120039.64,"total_display":"120,039.64","total_whole":"120,040","shares_owned_after":145249.0,"shares_owned_after_display":"145,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":2699338,"accession":"0001209191-16-121436","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-121436","line_url":"/filing/0001209191-16-121436#line-3","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5427.0,"shares_display":"5,427","price_per_share":15.91,"price_display":"15.91","price_state":"stated","total_value":86343.57,"total_display":"86,343.57","total_whole":"86,344","shares_owned_after":136844.0,"shares_owned_after_display":"136,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-17","filed_date":"2016-05-18","scope":"insider"},{"id":2310253,"accession":"0001209191-16-100249","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-100249","line_url":"/filing/0001209191-16-100249","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5711.0,"shares_display":"5,711","price_per_share":16.772150236385922,"price_display":"16.77","price_state":"stated","total_value":95785.75,"total_display":"95,785.75","total_whole":"95,786","shares_owned_after":128510.0,"shares_owned_after_display":"128,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-18","scope":"insider","n_lines":2},{"id":8944413,"accession":"0001209191-15-081097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-081097","line_url":"/filing/0001209191-15-081097","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7586.0,"shares_display":"7,586","price_per_share":31.22146243079357,"price_display":"31.22","price_state":"stated","total_value":236846.014,"total_display":"236,846.01","total_whole":"236,846","shares_owned_after":73657.0,"shares_owned_after_display":"73,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-17","filed_date":"2015-11-18","scope":"insider","n_lines":2},{"id":8603995,"accession":"0001209191-15-067017","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-067017","line_url":"/filing/0001209191-15-067017","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7711.0,"shares_display":"7,711","price_per_share":49.49110361820775,"price_display":"49.49","price_state":"stated","total_value":381625.9,"total_display":"381,625.90","total_whole":"381,626","shares_owned_after":69264.0,"shares_owned_after_display":"69,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider","n_lines":2},{"id":8603988,"accession":"0001209191-15-067017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-067017","line_url":"/filing/0001209191-15-067017#line-4","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612090","owner_name":"Soffer Gad","owner_display_name":"Soffer Gad","owner_url":"/insider/0001612090","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8778.0,"shares_display":"8,778","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":438900.0,"total_display":"438,900.00","total_whole":"438,900","shares_owned_after":73548.0,"shares_owned_after_display":"73,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP & Chief Strategy Officer)","n_filings":13,"first_seen":"2015-08-19","last_seen":"2017-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612090","retrieved_at":"2026-08-25T17:49:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}